Developer docs
API playgroundTry for free, no card

Search company profiles

Bioptická laboratoř

Full company profile

uuid003bxbn

Namestring
Bioptická laboratoř
Legal namestring
Bioptická laboratoř s.r.o.
Websiteurl
biopticka.cz
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Bioptická laboratoř s.r.o., founded in 2004 in Plzeň, Czech Republic, is the largest cytological and histopathological laboratory in the Czech Republic and one of the largest such facilities in Europe. The company operates an integrated diagnostic platform spanning cytology (Liquid Based Cytology augmented with the Hologic Genius AI system), biopsy interpretation (including IBEX AI for prostate biopsies), immunohistochemistry, HPV testing (Digene Hybrid Capture 2 and InnoLiPA), and molecular genetics/microbiology — processing approximately 1,000,000 cytology examinations, 200,000 biopsy samples, and 60,000+ genetic and molecular-pathology tests per year. It is one of only five Czech labs authorized by the Ministry of Health for cervical cancer screening cytology, holds ČSN EN ISO 15189 accreditation with a flexible scope for immunohistochemistry, and is the only Czech laboratory operating both an ICDP-UEMS Specialty Training Centre in Dermatopathology (accredited 2012) and an ESP Giordano Fellowship Genitourinary Pathology Training Centre (accredited 2015).

The business operates a hybrid revenue model: core diagnostic volumes are billed to Czech public health insurers under national screening and routine care contracts, while a growing self-pay channel (ZjistiCoTiJe.cz e-commerce storefront launched August 2025, Panorama NIPT, hereditary cancer panels, HPV genotyping) serves consumers directly. A separate professional services revenue stream comes from EU-accredited specialty training programs, recurring pathology conferences (Biopticka Multihead Tuesdays, KTF, BST, AMR symposia, dermatopathology summer schools), and authored monographs (Cutaneous Adnexal Tumors — Wolters Kluwer/LWW 2013; Nádory varlat — 2026). Go-to-market is sales-led for Czech clinicians (call-center hotlines per service line, free sample-collection kit delivery, WebZIS online portal, partner-gynecologist directory at gynekolog.cz), community-led for international trainees via the two EU-accredited training centers, and direct-to-consumer via the 2025 self-pay storefront. The customer base spans Czech gynecologists, dermatovenerologists, urologists, hospital pathology departments, self-pay patients, and international pathology trainees — anchored by a leadership team that includes internationally recognized Czech pathologists.

The company has no disclosed parent, no institutional investors, and is privately held as a Czech s.r.o. Recent strategic moves include the 2024 deployment of Hologic Genius AI and IBEX AI for clinical workflows, the 2025 launch of direct-to-consumer e-commerce, and the June 2026 AIxMed (Taiwan) memorandum on co-development of further AI diagnostic programs — collectively indicating an offensive push into AI-differentiated diagnostics and adjacent self-pay verticals while leveraging an entrenched Czech B2B referral base.

Short descriptiontext

Bioptická laboratoř s.r.o. is the largest cytological and histopathological laboratory in the Czech Republic, providing AI-augmented cytology, biopsy, immunohistochemistry, HPV testing, and molecular genetics diagnostics to Czech physicians, hospitals, self-pay patients, and international pathology trainees, with ~1M cytologies and 200k biopsies processed annually.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPlzen, Czechia
HQ citystring
Plzen
HQ countrystring
Czechia
HQ regionstring
Europe
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pathology diagnostic services, clinical laboratory testing, molecular genetic diagnostics, cytology screening, dermatopathology diagnostics
Industry5 codes
PRIMARYHLAFAMAA
Anatomic Pathology (Histopathology & Cytopathology)
SECONDARYHLAAALAI
Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays)
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLACAMAL
Lab Data Exchange & Interoperability (HL7/FHIR/LDT Results Delivery)
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHSABACAN
Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home)
Home & Personal Services/Elder Care & In-Home Care Services/Skilled Nursing & Clinical Home Health
NAICS code3 codes
  • Medical and Diagnostic Laboratories6215
  • Medical and Diagnostic Laboratories62151
  • Medical Laboratories621511
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Testing Laboratories8734
Product category
Pathology Diagnostic Services
Social media profiles1 record
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model5 records
1Health-insurance-reimbursed diagnostic services
TypeManaged Services
Description

Core revenue stream: biopsy, cytology, HPV testing, immunohistochemistry, molecular genetic testing and other diagnostics billed to Czech public health insurers (one of only 5 cytology labs accredited by the Czech Ministry of Health for cervical cancer screening).

biopticka.cz
2Self-pay (samoplátce) diagnostic testing
TypeTransaction Fee
Description

Direct-payment examinations including HPV genotyping (InnoLiPA), Panorama NIPT, genetic cancer predisposition testing, SARS-CoV-2 PCR/antigen/antibody testing for travelers, and the broader ZjistiCoTiJe.cz self-order channel launched in 2025.

biopticka.cz
3Professional education & training programs
TypeProfessional Services
Description

Revenue from ICDP-UEMS Dermatopathology Training Center (accredited 2012), ESP Genitourinary Pathology "Giordano Fellowship" Training Center (accredited 2015), international multihead-microscope courses (BST 2025, KTF, AMR Slide Symposium), ESF-funded vocational courses, and weekly Biopticka Multihead Tuesdays.

biopticka.cz
4Monograph and scientific publication sales
TypeLicensing Royalties
Description

Sales of authored monographs such as "Cutaneous Adnexal Tumors" (Wolters Kluwer/LWW, 814 pp., co-authored with P.H. McKee) and the 2026 monograph "Nádory varlat" (priced at 599 CZK).

biopticka.cz
5Conference & event sponsorship
TypeProfessional Services
Description

Sponsored scientific congresses (e.g., EBMWG 2019) and pathology meetings with industry partners (BioTech, Baria, Altium listed for BST 2025).

biopticka.cz
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain
Pricing details3 tiers
1Self-pay monograph "Nádory varlat" (2026)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

599 CZK per copy; ordered via email to winterova@biopticka.cz with invoicing address.

biopticka.cz
2Health-insurance-covered HPV testing
ModelOtherBilling cadencePay-as-you-go
Notes

Paid by Czech public health insurers when used to clarify diagnosis of cervical pre-cancers (~5% of cytology cases), per official guidelines; covers detection of 13 high-risk HPV types via Digene Hybrid Capture 2. Sample-collection kits and requisition forms supplied free of charge to referring clinicians.

biopticka.cz
3Self-pay HPV testing (InnoLiPA genotyping)
ModelOtherBilling cadencePay-as-you-go
Notes

Self-pay; detects individual HPV types including vaccine types 6, 11, 16, 18 via Innogenetics InnoLiPA. Specific price not disclosed.

biopticka.cz
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Bioptická laboratoř s.r.o. operates the largest cytological and histopathological laboratory in the Czech Republic, providing integrated diagnostic services across cytology, biopsy, immunohistochemistry, molecular genetics, dermatopathology, and HPV testing. The lab processes approximately 1 million cytology exams, 200,000 biopsies, and 60,000+ molecular-pathology tests annually, supported by AI-augmented workflows (Hologic Genius, IBEX) and the proprietary WebZIS results portal. Services are delivered to Czech clinicians and hospitals under contracts with public health insurers, with a parallel self-pay channel for consumers via dedicated websites.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Bioptická laboratoř s.r.o. is a large, integrated diagnostic pathology laboratory — not a single SaaS product but a portfolio of specialized diagnostic service modules supported by digital platforms. The core offerings comprise Biopsie (with on-site Immunohistochemistry), Cytologie (including Liquid Based Cytology with AI-assisted Genius evaluation), Molekulární genetika a mikrobiologie (molecular genetics and microbiology/virology), Dermatopatologie, and HPV testing. These core diagnostic services are complemented by named products/modules: WebZIS (online results portal), the PANORAMA® NIPT non-invasive prenatal test, ZjistiCoTiJe.cz (direct-to-consumer lab test ordering website), Diagnostika autoimunitních bulózních onemocnění (autoimmune bullous disease diagnostics using Euroimun ELISA), Diagnostika koronaviru SARS-CoV-2 (NGS-based coronavirus sequencing and antibody testing), and Vyšetření genetické predispozice karcinomu prsu (hereditary cancer genetic predisposition testing). Two accredited training centers — the ICDP-UEMS Dermatopathology Training Center and the ESP Genitourinary Pathology Training Center (Giordano Fellowship) — extend the offering into medical education. AI capability is embedded in the cytology workflow via the Hologic Genius system and in prostate biopsy interpretation via the IBEX AI program.

Product and service15 records
1Biopsie (Biopsy examinations)
CategoryCore diagnostic service - Histopathology
Description

Complete biopsy diagnostic service with direct follow-up to immunohistochemical and necessary molecular genetic examinations for referring Czech clinicians and hospitals; approximately 200,000 biopsy samples processed annually.

2Cytologie (Cytology with LBC and AI-assisted Hologic Genius)
CategoryCore diagnostic service - Cytology
Description

Investigation of gynecological cytology (oncological and functional examinations of smears from the cervix, vaginal mucosa, vulva and endometrium) and non-gynecological cytology; approximately 1,000,000 cytological examinations processed annually, differentiated by Liquid Based Cytology (LBC) with Hologic Genius AI evaluation.

3Imunohistochemie (Immunohistochemistry)
CategoryCore diagnostic service - Histopathology
Description

Immunohistochemical examinations carried out under a flexible scope of accreditation granted by the Czech Institute for Accreditation (ČIA), providing direct follow-up to biopsy examinations and supporting tumor classification.

4Molekulární genetika a mikrobiologie (Molecular genetics and microbiology)
CategoryCore diagnostic service - Molecular genetics
Description

Molecular genetic examinations performed on cytology and biopsy specimens in the diagnosis of tumor diseases and infectious processes; the largest Czech genetic facility focused on oncological diagnostics, performing more than 60,000 genetic and molecular-pathology tests annually including predictive oncology testing.

5Dermatopatologie (Dermatopathology)
CategoryCore diagnostic service - Dermatopathology
Description

Specialized dermatopathology diagnostics staffed by European-certified specialists holding the "Diploma in Dermatopathology" from the International Committee for Dermatopathology (ICDP), including autoantibody ELISA testing for autoimmune bullous diseases.

6HPV vyšetření (HPV testing)
CategoryDiagnostic test - HPV
Description

HPV testing for cervical cancer prevention, paid by Czech public health insurers within the national screening programme as well as for self-pay patients, using Digene Hybrid Capture 2 (13 high-risk HPV types) and InnoLiPA genotyping (vaccine types 6, 11, 16, 18).

7WebZIS (online results and requisition portal)
CategoryDigital platform
Description

Web-based information system providing clinicians with internet access to histological and cytological examination results and enabling online requisition submission from any internet-connected device.

8PANORAMA® NIPT test (non-invasive prenatal testing)
CategoryGenetic test - NIPT
Description

Non-invasive prenatal test (NIPT) offered using the Panorama™ test from Natera, detecting the most common fetal genetic defects from the pregnant woman's blood, available to self-paying pregnant women through a dedicated microsite.

9Diagnostika autoimunitních bulózních onemocnění (Autoimmune bullous disease diagnostics)
CategoryDiagnostic test - Autoimmune bullous disease
Description

IgG autoantibody testing from blood by ELISA using a certified Euroimmun kit covering 6 antigens (BP180, BP230, desmoglein 1, desmoglein 3, envoplakin, collagen VII) plus IgA antibodies against gliadin for dermatitis herpetiformis, complementing direct immunofluorescence for autoimmune bullous disease diagnostics.

10Diagnostika SARS-CoV-2 (SARS-CoV-2 PCR/antigen/antibody testing and NGS genome sequencing)
CategoryDiagnostic test - Infectious disease
Description

SARS-CoV-2 PCR, antigen and antibody testing for self-pay patients (including travelers) plus routine NGS-based whole-genome sequencing of positive samples to identify viral mutations and assign lineages.

11Vyšetření genetické predispozice k nádorovým onemocněním (Hereditary cancer predisposition testing)
CategoryGenetic test - Hereditary cancer
Description

Genetic testing of inherited predisposition to hereditary cancer (e.g., breast cancer) for self-pay patients, offered through a dedicated microsite (dedicne.nadory.cz).

12ZjistiCoTiJe.cz (direct-order self-pay lab testing storefront)
CategoryDigital platform - Direct-to-consumer
Description

Self-pay e-commerce website allowing Czech consumers to order selected laboratory examinations (HPV genotyping, Panorama NIPT, hereditary cancer panels, others) without a doctor's requisition.

13ICDP-UEMS Dermatopathology Training Center
CategoryEducation and training service
Description

EU-accredited specialty training center offering multi-week/month fellowships in dermatopathology at the Rejskova "Eden" facility, attracting international trainees and supporting second-opinion consultations.

14ESP Genitourinary Pathology Training Center (Giordano Fellowship)
CategoryEducation and training service
Description

ESP-accredited specialty training center offering genitourinary pathology training and fellowships, coordinated with the European Society of Pathology and listed on the ESP webpage.

15Monografie "Nádory varlat" (Testicular Tumors monograph)
CategoryScientific publication
Description

Expert Czech-language monograph on testicular tumors providing latest findings, practical procedures and recommendations in histopathology and oncology, distributed by Bioptická laboratoř for 599 CZK per copy.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership18 partners
Strategic tierFlagship — Explicit Czech–Taiwan Memorandum For Joint Ai Diagnostic Program DevelopmentTypeStrategic or Co-development PartnerAnnounced on2026-06-02
Description

Memorandum of cooperation signed on 2 June 2026 in Taiwan by doc. MUDr. Michael Michal, Ph.D. and MUDr. Robert Slunéčko (Bioptická laboratoř) with AIxMed (Taiwanese software firm). Defines framework for future co-development of additional AI-powered diagnostic programs and broader deployment of digital tools in healthcare.

Strategic tierCore — Underpins Cervical Cancer Screening Ai StrategyTypeTechnology or Integration
Description

Hologic provides the Genius AI system for cervical cytology evaluation, including 2 scanners (~€1M each) and 6 reading stations (~€50,000 each) with EMA and FDA certification. Press release issued via Hologic's Czech distributor Biomedica. Hologic planned an additional AI version for urinary cytology at end of 2024.

Strategic tierCore — Used For All Thin-Needle Prostate Biopsies Read At The LabTypeTechnology or Integration
Description

IBEX AI program deployed in June 2024 to read all thin-needle prostate biopsies, materially reducing missed small adenocarcinomas. Demoed at the IBEX booth during the 6th Urogenital Pathology Meeting (KTF 2024, Mikulov 13–15 June 2024); doc. Pivovarčíková lectured on the topic.

Strategic tierSupportingTypeChannel Partner/ Reseller/ Distributor
Description

Local Czech distributor of Hologic; co-issued the Genius press release announcing the AI cytology deployment at Bioptická laboratoř.

5Digene (Qiagen) — Hybrid Capture 2
Strategic tierSupporting — Sole Hpv Testing Platform Reimbursed By Czech InsurersTypeOEM/ Whitelabel/ Licensing Partner
Description

Hybrid Capture 2 platform used for the 13 high-risk HPV types detection covered by Czech health insurance for cervical cancer screening triage.

biopticka.cz
Strategic tierSupporting — Hpv Genotyping Platform For Self-Pay PatientsTypeOEM/ Whitelabel/ Licensing Partner
Description

InnoLiPA HPV genotyping platform (individual types including vaccine types 6, 11, 16, 18) used for self-pay HPV testing.

Strategic tierSupportingTypeOEM/ Whitelabel/ Licensing Partner
Description

Euroimun certified ELISA kit used since June 2021 for IgG autoantibody testing in autoimmune bullous diseases, complementing direct immunofluorescence.

8Panorama (Natera) — NIPT
Strategic tierCore — Primary Non-Invasive Prenatal Testing OfferingTypeOEM/ Whitelabel/ Licensing Partner
Description

Panorama non-invasive prenatal test offered through a dedicated microsite panoramatest.cz; described by the lab as the most reliable NIPT globally.

biopticka.cz
9European Society of Pathology (ESP)
Strategic tierFlagship — Esp-Accredited Giordano Fellowship Training CenterTypeStrategic or Co-development Partner
Description

ESP awarded the lab's Šikl's Department of Pathology accreditation as ESP Advanced Training Centre "Giordano Fellowship" in 2015 for Genitourinary Pathology training; program coordinated with the ESP and listed on the ESP webpage.

biopticka.cz
10International Committee for Dermatopathology / UEMS (ICDP-UEMS)
Strategic tierFlagship — Eu-Accredited Dermatopathology Training CenterTypeStrategic or Co-development Partner
Description

ICDP-UEMS accreditation as Specialty Training Centre in Dermatopathology — granted to Bioptická laboratoř s.r.o. in 2012 and to the Šikl Department of Pathology in 2014. Co-organizers of trainee symposia and histopathology internships at the Rejskova "Eden" facility.

biopticka.cz
11European Bone Marrow Working Group (EBMWG)
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Hosted the EBMWG 2019 Scientific and Business Meeting (25–26 October 2019) at Rejskova 10, Pilsen; local organizer was Ludmila Boudová.

biopticka.cz
12Šikl's Department of Pathology, University Hospital and Medical Faculty of Charles University in Pilsen
Strategic tierFlagship — Joint Clinical-Academic Pathology OperationTypeStrategic or Co-development Partner
Description

Long-standing institutional collaboration with Charles University's Šikl's Department of Pathology; co-accredited training sites, joint scientific programs, and co-hosted conferences including BST 2025 (course director Michael Michal, joint affiliation).

biopticka.cz
13Lékařská fakulta Univerzity Karlovy v Plzni (Charles University Faculty of Medicine in Pilsen)
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Academic affiliation for Ph.D. students (e.g., Antonina Kalmykova) and joint educational/research activities.

biopticka.cz
14BioTech, Baria, Altium — BST 2025 industry partners/sponsors
Strategic tierSupportingTypeGTM or Marketing Partner
Description

Industry sponsors of the 1st Bone and Soft Tissue Pathology Meeting (February 2025, Pilsen); logos displayed on meeting materials.

biopticka.cz
15Arkadi M. Rywlin International Pathology Slide Seminar Club
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Co-organizer of the 2nd (Srni 2005) and 13th (Pilsen 16–18 June 2025) Arkadi M. Rywlin International Pathology Slide Symposium in Anatomic Pathology.

biopticka.cz
16Kidney Tumor Friends (KTF)
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Co-organizes the Urogenital Pathology Meetings (3rd 2014 Mikulov, 5th 2021 Pilsen, 6th 2024 Mikulov) in honour of Prof. Ondřej Hes, founder of KTF.

biopticka.cz
17Association of Clinical Pathologists (ACP)
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Sponsored the ACP Histopathology Courses in Pilsen (February 2008).

biopticka.cz
Strategic tierSupportingTypeGTM or Marketing Partner
Description

Press release distribution partner (used for the 8 July 2024 Biomedica × Bioptická Laboratoř Genius AI announcement).

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat7 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bioptická laboratoř

Pathology Diagnostic Servicesbiopticka.cz

Bioptická laboratoř s.r.o. is the largest cytological and histopathological laboratory in the Czech Republic, providing AI-augmented cytology, biopsy, immunohistochemistry, HPV testing, and molecular genetics diagnostics to Czech physicians, hospitals, self-pay patients, and international pathology trainees, with ~1M cytologies and 200k biopsies processed annually.

What Bioptická laboratoř does

Bioptická laboratoř s.r.o., founded in 2004 in Plzeň, Czech Republic, is the largest cytological and histopathological laboratory in the Czech Republic and one of the largest such facilities in Europe. The company operates an integrated diagnostic platform spanning cytology (Liquid Based Cytology augmented with the Hologic Genius AI system), biopsy interpretation (including IBEX AI for prostate biopsies), immunohistochemistry, HPV testing (Digene Hybrid Capture 2 and InnoLiPA), and molecular genetics/microbiology — processing approximately 1,000,000 cytology examinations, 200,000 biopsy samples, and 60,000+ genetic and molecular-pathology tests per year. It is one of only five Czech labs authorized by the Ministry of Health for cervical cancer screening cytology, holds ČSN EN ISO 15189 accreditation with a flexible scope for immunohistochemistry, and is the only Czech laboratory operating both an ICDP-UEMS Specialty Training Centre in Dermatopathology (accredited 2012) and an ESP Giordano Fellowship Genitourinary Pathology Training Centre (accredited 2015).

The business operates a hybrid revenue model: core diagnostic volumes are billed to Czech public health insurers under national screening and routine care contracts, while a growing self-pay channel (ZjistiCoTiJe.cz e-commerce storefront launched August 2025, Panorama NIPT, hereditary cancer panels, HPV genotyping) serves consumers directly. A separate professional services revenue stream comes from EU-accredited specialty training programs, recurring pathology conferences (Biopticka Multihead Tuesdays, KTF, BST, AMR symposia, dermatopathology summer schools), and authored monographs (Cutaneous Adnexal Tumors — Wolters Kluwer/LWW 2013; Nádory varlat — 2026). Go-to-market is sales-led for Czech clinicians (call-center hotlines per service line, free sample-collection kit delivery, WebZIS online portal, partner-gynecologist directory at gynekolog.cz), community-led for international trainees via the two EU-accredited training centers, and direct-to-consumer via the 2025 self-pay storefront. The customer base spans Czech gynecologists, dermatovenerologists, urologists, hospital pathology departments, self-pay patients, and international pathology trainees — anchored by a leadership team that includes internationally recognized Czech pathologists.

The company has no disclosed parent, no institutional investors, and is privately held as a Czech s.r.o. Recent strategic moves include the 2024 deployment of Hologic Genius AI and IBEX AI for clinical workflows, the 2025 launch of direct-to-consumer e-commerce, and the June 2026 AIxMed (Taiwan) memorandum on co-development of further AI diagnostic programs — collectively indicating an offensive push into AI-differentiated diagnostics and adjacent self-pay verticals while leveraging an entrenched Czech B2B referral base.

Bioptická laboratoř firmographics

Firmographics
Name
Bioptická laboratoř
Legal name
Bioptická laboratoř s.r.o.
Website
https://biopticka.cz
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
Bioptická laboratoř s.r.o. is the largest cytological and histopathological laboratory in the Czech Republic, providing AI-augmented cytology, biopsy, immunohistochemistry, HPV testing, and molecular genetics diagnostics to Czech physicians, hospitals, self-pay patients, and international pathology trainees, with ~1M cytologies and 200k biopsies processed annually.
Ownership category
akta.pro rank

Bioptická laboratoř industry classification

Industry
Product category
Pathology Diagnostic Services
NAICS
Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAFAMAA
Anatomic Pathology (Histopathology & Cytopathology)
SECONDARYHLAAALAI
Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays)
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLACAMAL
Lab Data Exchange & Interoperability (HL7/FHIR/LDT Results Delivery)
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHSABACAN
Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home)
Home & Personal Services/Elder Care & In-Home Care Services/Skilled Nursing & Clinical Home Health

Keywords

  • Pathology diagnostic services
  • Clinical laboratory testing
  • Molecular genetic diagnostics
  • Cytology screening
  • Dermatopathology diagnostics

Where Bioptická laboratoř is headquartered

Location

Headquarters

HQ city
Plzen
HQ country
Czechia
HQ region
Europe

Offices6 records

Markets served

Bioptická laboratoř business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Health-insurance-reimbursed diagnostic services: Core revenue stream: biopsy, cytology, HPV testing, immunohistochemistry, molecular genetic testing and other diagnostics billed to Czech public health insurers (one of only 5 cytology labs accredited by the Czech Ministry of Health for cervical cancer screening).
  2. Self-pay (samoplátce) diagnostic testing: Direct-payment examinations including HPV genotyping (InnoLiPA), Panorama NIPT, genetic cancer predisposition testing, SARS-CoV-2 PCR/antigen/antibody testing for travelers, and the broader ZjistiCoTiJe.cz self-order channel launched in 2025.
  3. Professional education & training programs: Revenue from ICDP-UEMS Dermatopathology Training Center (accredited 2012), ESP Genitourinary Pathology "Giordano Fellowship" Training Center (accredited 2015), international multihead-microscope courses (BST 2025, KTF, AMR Slide Symposium), ESF-funded vocational courses, and weekly Biopticka Multihead Tuesdays.
  4. Monograph and scientific publication sales: Sales of authored monographs such as "Cutaneous Adnexal Tumors" (Wolters Kluwer/LWW, 814 pp., co-authored with P.H. McKee) and the 2026 monograph "Nádory varlat" (priced at 599 CZK).
  5. Conference & event sponsorship: Sponsored scientific congresses (e.g., EBMWG 2019) and pathology meetings with industry partners (BioTech, Baria, Altium listed for BST 2025).

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goSelf-pay monograph "Nádory varlat" (2026)
OtherPay-as-you-goHealth-insurance-covered HPV testing
OtherPay-as-you-goSelf-pay HPV testing (InnoLiPA genotyping)

Go-to-market motion4 records

Distribution channels6 records

Marketing channels8 records

Bioptická laboratoř product offering

Product offering

Core offering

Bioptická laboratoř s.r.o. operates the largest cytological and histopathological laboratory in the Czech Republic, providing integrated diagnostic services across cytology, biopsy, immunohistochemistry, molecular genetics, dermatopathology, and HPV testing. The lab processes approximately 1 million cytology exams, 200,000 biopsies, and 60,000+ molecular-pathology tests annually, supported by AI-augmented workflows (Hologic Genius, IBEX) and the proprietary WebZIS results portal. Services are delivered to Czech clinicians and hospitals under contracts with public health insurers, with a parallel self-pay channel for consumers via dedicated websites.

Product overview

Bioptická laboratoř s.r.o. is a large, integrated diagnostic pathology laboratory — not a single SaaS product but a portfolio of specialized diagnostic service modules supported by digital platforms. The core offerings comprise Biopsie (with on-site Immunohistochemistry), Cytologie (including Liquid Based Cytology with AI-assisted Genius evaluation), Molekulární genetika a mikrobiologie (molecular genetics and microbiology/virology), Dermatopatologie, and HPV testing. These core diagnostic services are complemented by named products/modules: WebZIS (online results portal), the PANORAMA® NIPT non-invasive prenatal test, ZjistiCoTiJe.cz (direct-to-consumer lab test ordering website), Diagnostika autoimunitních bulózních onemocnění (autoimmune bullous disease diagnostics using Euroimun ELISA), Diagnostika koronaviru SARS-CoV-2 (NGS-based coronavirus sequencing and antibody testing), and Vyšetření genetické predispozice karcinomu prsu (hereditary cancer genetic predisposition testing). Two accredited training centers — the ICDP-UEMS Dermatopathology Training Center and the ESP Genitourinary Pathology Training Center (Giordano Fellowship) — extend the offering into medical education. AI capability is embedded in the cytology workflow via the Hologic Genius system and in prostate biopsy interpretation via the IBEX AI program.

Differentiator

Problem solved

Functional benefit

Products and services

  • Biopsie (Biopsy examinations) Complete biopsy diagnostic service with direct follow-up to immunohistochemical and necessary molecular genetic examinations for referring Czech clinicians and hospitals; approximately 200,000 biopsy samples processed annually.
  • Cytologie (Cytology with LBC and AI-assisted Hologic Genius) Investigation of gynecological cytology (oncological and functional examinations of smears from the cervix, vaginal mucosa, vulva and endometrium) and non-gynecological cytology; approximately 1,000,000 cytological examinations processed annually, differentiated by Liquid Based Cytology (LBC) with Hologic Genius AI evaluation.
  • Imunohistochemie (Immunohistochemistry) Immunohistochemical examinations carried out under a flexible scope of accreditation granted by the Czech Institute for Accreditation (ČIA), providing direct follow-up to biopsy examinations and supporting tumor classification.
  • Molekulární genetika a mikrobiologie (Molecular genetics and microbiology) Molecular genetic examinations performed on cytology and biopsy specimens in the diagnosis of tumor diseases and infectious processes; the largest Czech genetic facility focused on oncological diagnostics, performing more than 60,000 genetic and molecular-pathology tests annually including predictive oncology testing.
  • Dermatopatologie (Dermatopathology) Specialized dermatopathology diagnostics staffed by European-certified specialists holding the "Diploma in Dermatopathology" from the International Committee for Dermatopathology (ICDP), including autoantibody ELISA testing for autoimmune bullous diseases.
  • HPV vyšetření (HPV testing) HPV testing for cervical cancer prevention, paid by Czech public health insurers within the national screening programme as well as for self-pay patients, using Digene Hybrid Capture 2 (13 high-risk HPV types) and InnoLiPA genotyping (vaccine types 6, 11, 16, 18).
  • WebZIS (online results and requisition portal) Web-based information system providing clinicians with internet access to histological and cytological examination results and enabling online requisition submission from any internet-connected device.
  • PANORAMA® NIPT test (non-invasive prenatal testing) Non-invasive prenatal test (NIPT) offered using the Panorama™ test from Natera, detecting the most common fetal genetic defects from the pregnant woman's blood, available to self-paying pregnant women through a dedicated microsite.
  • Diagnostika autoimunitních bulózních onemocnění (Autoimmune bullous disease diagnostics) IgG autoantibody testing from blood by ELISA using a certified Euroimmun kit covering 6 antigens (BP180, BP230, desmoglein 1, desmoglein 3, envoplakin, collagen VII) plus IgA antibodies against gliadin for dermatitis herpetiformis, complementing direct immunofluorescence for autoimmune bullous disease diagnostics.
  • Diagnostika SARS-CoV-2 (SARS-CoV-2 PCR/antigen/antibody testing and NGS genome sequencing) SARS-CoV-2 PCR, antigen and antibody testing for self-pay patients (including travelers) plus routine NGS-based whole-genome sequencing of positive samples to identify viral mutations and assign lineages.
  • Vyšetření genetické predispozice k nádorovým onemocněním (Hereditary cancer predisposition testing) Genetic testing of inherited predisposition to hereditary cancer (e.g., breast cancer) for self-pay patients, offered through a dedicated microsite (dedicne.nadory.cz).
  • ZjistiCoTiJe.cz (direct-order self-pay lab testing storefront) Self-pay e-commerce website allowing Czech consumers to order selected laboratory examinations (HPV genotyping, Panorama NIPT, hereditary cancer panels, others) without a doctor's requisition.
  • ICDP-UEMS Dermatopathology Training Center EU-accredited specialty training center offering multi-week/month fellowships in dermatopathology at the Rejskova "Eden" facility, attracting international trainees and supporting second-opinion consultations.
  • ESP Genitourinary Pathology Training Center (Giordano Fellowship) ESP-accredited specialty training center offering genitourinary pathology training and fellowships, coordinated with the European Society of Pathology and listed on the ESP webpage.
  • Monografie "Nádory varlat" (Testicular Tumors monograph) Expert Czech-language monograph on testicular tumors providing latest findings, practical procedures and recommendations in histopathology and oncology, distributed by Bioptická laboratoř for 599 CZK per copy.

Companies that use Bioptická laboratoř

Customer profile

Segments7 records

Ideal customer profiles6 records

Bioptická laboratoř technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability3 records

Feature6 records

Bioptická laboratoř partnerships and signals

Strategic signal

Partnerships

18 partnerships are on record, tiered flagship — explicit czech–taiwan memorandum for joint ai diagnostic program development, core — underpins cervical cancer screening ai strategy, core — used for all thin-needle prostate biopsies read at the lab, supporting, supporting — sole hpv testing platform reimbursed by czech insurers, supporting — hpv genotyping platform for self-pay patients, core — primary non-invasive prenatal testing offering, flagship — esp-accredited giordano fellowship training center, flagship — eu-accredited dermatopathology training center and flagship — joint clinical-academic pathology operation.

  • AIxMedflagship — explicit czech–taiwan memorandum for joint ai diagnostic program developmentStrategic or Co-development Partner · 2 June 2026Memorandum of cooperation signed on 2 June 2026 in Taiwan by doc. MUDr. Michael Michal, Ph.D. and MUDr. Robert Slunéčko (Bioptická laboratoř) with AIxMed (Taiwanese software firm). Defines framework for future co-development of additional AI-powered diagnostic programs and broader deployment of digital tools in healthcare.
  • Hologic (Genius AI system)core — underpins cervical cancer screening ai strategyTechnology or IntegrationHologic provides the Genius AI system for cervical cytology evaluation, including 2 scanners (~€1M each) and 6 reading stations (~€50,000 each) with EMA and FDA certification. Press release issued via Hologic's Czech distributor Biomedica. Hologic planned an additional AI version for urinary cytology at end of 2024.
  • IBEX (prostate biopsy AI)core — used for all thin-needle prostate biopsies read at the labTechnology or IntegrationIBEX AI program deployed in June 2024 to read all thin-needle prostate biopsies, materially reducing missed small adenocarcinomas. Demoed at the IBEX booth during the 6th Urogenital Pathology Meeting (KTF 2024, Mikulov 13–15 June 2024); doc. Pivovarčíková lectured on the topic.
  • Biomedica (Hologic distributor for Czech Republic)supportingChannel Partner/ Reseller/ DistributorLocal Czech distributor of Hologic; co-issued the Genius press release announcing the AI cytology deployment at Bioptická laboratoř.
  • Digene (Qiagen) — Hybrid Capture 2supporting — sole hpv testing platform reimbursed by czech insurersOEM/ Whitelabel/ Licensing PartnerHybrid Capture 2 platform used for the 13 high-risk HPV types detection covered by Czech health insurance for cervical cancer screening triage.
  • Innogenetics — InnoLiPAsupporting — hpv genotyping platform for self-pay patientsOEM/ Whitelabel/ Licensing PartnerInnoLiPA HPV genotyping platform (individual types including vaccine types 6, 11, 16, 18) used for self-pay HPV testing.
  • EuroimunsupportingOEM/ Whitelabel/ Licensing PartnerEuroimun certified ELISA kit used since June 2021 for IgG autoantibody testing in autoimmune bullous diseases, complementing direct immunofluorescence.
  • Panorama (Natera) — NIPTcore — primary non-invasive prenatal testing offeringOEM/ Whitelabel/ Licensing PartnerPanorama non-invasive prenatal test offered through a dedicated microsite panoramatest.cz; described by the lab as the most reliable NIPT globally.
  • European Society of Pathology (ESP)flagship — esp-accredited giordano fellowship training centerStrategic or Co-development PartnerESP awarded the lab's Šikl's Department of Pathology accreditation as ESP Advanced Training Centre "Giordano Fellowship" in 2015 for Genitourinary Pathology training; program coordinated with the ESP and listed on the ESP webpage.
  • International Committee for Dermatopathology / UEMS (ICDP-UEMS)flagship — eu-accredited dermatopathology training centerStrategic or Co-development PartnerICDP-UEMS accreditation as Specialty Training Centre in Dermatopathology — granted to Bioptická laboratoř s.r.o. in 2012 and to the Šikl Department of Pathology in 2014. Co-organizers of trainee symposia and histopathology internships at the Rejskova "Eden" facility.
  • European Bone Marrow Working Group (EBMWG)supportingStrategic or Co-development PartnerHosted the EBMWG 2019 Scientific and Business Meeting (25–26 October 2019) at Rejskova 10, Pilsen; local organizer was Ludmila Boudová.
  • Šikl's Department of Pathology, University Hospital and Medical Faculty of Charles University in Pilsenflagship — joint clinical-academic pathology operationStrategic or Co-development PartnerLong-standing institutional collaboration with Charles University's Šikl's Department of Pathology; co-accredited training sites, joint scientific programs, and co-hosted conferences including BST 2025 (course director Michael Michal, joint affiliation).
  • Lékařská fakulta Univerzity Karlovy v Plzni (Charles University Faculty of Medicine in Pilsen)supportingStrategic or Co-development PartnerAcademic affiliation for Ph.D. students (e.g., Antonina Kalmykova) and joint educational/research activities.
  • BioTech, Baria, Altium — BST 2025 industry partners/sponsorssupportingGTM or Marketing PartnerIndustry sponsors of the 1st Bone and Soft Tissue Pathology Meeting (February 2025, Pilsen); logos displayed on meeting materials.
  • Arkadi M. Rywlin International Pathology Slide Seminar ClubsupportingStrategic or Co-development PartnerCo-organizer of the 2nd (Srni 2005) and 13th (Pilsen 16–18 June 2025) Arkadi M. Rywlin International Pathology Slide Symposium in Anatomic Pathology.
  • Kidney Tumor Friends (KTF)supportingStrategic or Co-development PartnerCo-organizes the Urogenital Pathology Meetings (3rd 2014 Mikulov, 5th 2021 Pilsen, 6th 2024 Mikulov) in honour of Prof. Ondřej Hes, founder of KTF.
  • Association of Clinical Pathologists (ACP)supportingStrategic or Co-development PartnerSponsored the ACP Histopathology Courses in Pilsen (February 2008).
  • Protext (ČTK press release service)supportingGTM or Marketing PartnerPress release distribution partner (used for the 8 July 2024 Biomedica × Bioptická Laboratoř Genius AI announcement).

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Bioptická laboratoř competitors and assessment

Company assessment

Market position

Competitive moat7 records

Key highlights7 records

Customer concentration

Bioptická laboratoř social profiles

Digital presence

Bioptická laboratoř compliance and trust

Trust signal

Compliance6 records

Bioptická laboratoř financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bioptická laboratoř leadership team

Management profile

Number of profiles

Profiles11 records

Bioptická laboratoř funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bioptická laboratoř M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioptická laboratoř

What does Bioptická laboratoř do?

Bioptická laboratoř s.r.o. operates the largest cytological and histopathological laboratory in the Czech Republic, providing integrated diagnostic services across cytology, biopsy, immunohistochemistry, molecular genetics, dermatopathology, and HPV testing. The lab processes approximately 1 million cytology exams, 200,000 biopsies, and 60,000+ molecular-pathology tests annually, supported by AI-augmented workflows (Hologic Genius, IBEX) and the proprietary WebZIS results portal. Services are delivered to Czech clinicians and hospitals under contracts with public health insurers, with a parallel self-pay channel for consumers via dedicated websites.

Is Bioptická laboratoř a public or private company?

Bioptická laboratoř is a private company. It is classified as family owned and is currently operating.

When was Bioptická laboratoř founded?

Bioptická laboratoř was founded in 2004. It employs 11 to 50 people.

Where is Bioptická laboratoř based?

Bioptická laboratoř is headquartered in Plzen, Czechia, in the Europe region.

How does Bioptická laboratoř make money?

Five revenue lines are on record. Health-insurance-reimbursed diagnostic services are the primary driver. The others are self-pay (samoplátce) diagnostic testing, professional education & training programs, monograph and scientific publication sales and conference & event sponsorship.

Does Bioptická laboratoř have an API?

No public API is recorded for Bioptická laboratoř.

What industry is Bioptická laboratoř in?

Bioptická laboratoř's product category is Pathology Diagnostic Services. Its primary akta.pro industry code is HLAFAMAA, Anatomic Pathology (Histopathology & Cytopathology), with a secondary code of HLAAALAI, Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays). Its NAICS code is 6215 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals